Sensorium Therapeutics, Inc. — Form D/A
Sensorium Therapeutics, Inc. of MEDFORD, MA, a company, filed a Form D amendment with the SEC on 2023-12-06. The offering totals $24.8M, of which $24.7M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2023-12-06
- Form: D/A
- Accession: 0001874823-23-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $24.8M
- Amount sold: $24.7M
- Remaining: $100K
- Investors: 64
- Date of first sale: 2022-09-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-460645
Issuer
- Name: Sensorium Therapeutics, Inc.
- CIK: 0001874823
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 47 HIGH ST. #513, MEDFORD, MA, 02155
- Phone: (339) 329-2333
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Richard Simon | Executive Officer | Medford, MA |
| Pranav Tadi | Executive Officer | Boston, MA |
| David Southwell | Director | NEW YORK, NY |
| Jerrold Rosenbaum | Director | Claymont, DE |
| Ryan Katz | Director | Medford, MA |
| Kevin Lalande | Director | Medford, MA |
| Richard Simon | Director | Medford, MA |
| Balkrishan Gill | Director | Medford, MA |
| Alexandra Glucksmann | Director | Medford, MA |
| Alexandra Glucksmann | Executive Officer | Medford, MA |
| Jacob Hooker | Director | Medford, MA |
| Jacob Hooker | Executive Officer | Medford, MA |
Other filings by this issuer (4)
More